polypill

(redirected from Polycap)
Also found in: Medical.
Related to Polycap: Polycarp

polypill

(ˈpɒlɪˌpɪl)
n
(Medicine) a proposed medication intended to reduce the likelihood of heart attacks and strokes, containing doses of different drugs to lower blood cholesterol, control blood pressure, and reduce the clotting tendency of the blood
References in periodicals archive ?
Allan M Polycap (@AllanPolycap) joked on Twitter, 'Mr CS @RaphaelTuju can I be your PS or CAS?
Cadila Pharmaceuticals has recently emerged on the world map with the development of Polycap - a novel and world's first drug combination for primary prevention of cardiovascular heart disease (CHD).
The concept is back in favour with an Indian generic manufacturer making the running (The Indian Polycap Study, Lancet 2009; 373: 1341-1352).
This article in the Lancet comes from the India Polycap study, which examined the effects of the polypill--a combined statin, aspirin and folic acid with three blood pressure-lowering drugs (ramipril, atenolol and hydrochlorothiazide)--in middle-aged people without known cardiovascular disease.
The Indian Polycap Study (TIPS) enrolled people aged 45-80 years with a single CVD risk factor: type 2 diabetes, moderately elevated blood pressure (above 140/90 mm Hg but below 160/100 mm Hg), smoking within the prior 5 years, an LDL cholesterol above 3.
The Indian Polycap Study (TIPS) enrolled people aged 4580 years with a single CVD risk factor: type 2 diabetes, moderately elevated blood pressure (more than 140/90 mm Hg but less than 160/100 mm Hg), smoking within the prior 5 years, serum LDL cholesterol of more than 3.
Scientists compared Polycap, a five-drug polypill, with combinations of its different components to assess effectiveness and safety.
Polycap, dubbed the "polypill", includes a combination of statins, aspirin, a beta-blocker, ace inhibitor and a diuretic - medication already used individually to lower cholesterol and blood pressure, major cardiovascular disease risk factors.
In the trial led by Salim Yusuf at McMaster University in Hamilton, Canada, scientists tested the five-drug polypill - called Polycap - in healthy individuals with one cardiovascular risk factor, such as being overweight, having smoked in the past five years, or having type-2 diabetes.
Polycap, a five-drug "polypill", contains aspirin to combat clotting, a cholesterol-lowering statin and three blood pressure-lowering drugs.